About
UNOMR, a techBio startup from ETH Zurich, is pioneering single-molecule protein sequencing through their innovative interface nanopore sensor, currently with a focus on site-specific protein glycosylation. Adressing a US$ 60B market, their patented solution has far-reaching applications across healthcare, pharmaceutical development, and food science, offering a powerful new tool for therapeutic discovery and medical food product innovation. Driven by the vision of bringing advanced proteomics directly to the patient, UNOMR aims to catalyze the next breakthrough in precision medicine by making sophisticated protein analysis accessible.
Covered funding stages of your organization / Spin-off Funding Stage
Industry Sector your organization invests in / Industry Sector of your Spin-off
Target Markets of your organization / Expansion or target markets of your spin-off
Representatives
CEO & co-founder UNOMR AG
UNOMR AG
COO at UNOMR
UNOMR AG
CTO & Co-Founder
UNOMR AG